Bristol-Myers Squibb Co (BMY)
43.67
-0.37
(-0.84%)
USD |
NYSE |
May 08, 16:00
43.67
0.00 (0.00%)
After-Hours: 19:49
Bristol-Myers Squibb Price to Book Value: 5.368 for May 8, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 5.414 |
| May 06, 2024 | 5.397 |
| May 03, 2024 | 5.408 |
| May 02, 2024 | 5.372 |
| May 01, 2024 | 5.435 |
| April 30, 2024 | 5.402 |
| April 29, 2024 | 5.488 |
| April 26, 2024 | 5.513 |
| April 25, 2024 | 5.495 |
| April 24, 2024 | 6.006 |
| April 23, 2024 | 6.022 |
| April 22, 2024 | 6.041 |
| April 19, 2024 | 6.015 |
| April 18, 2024 | 5.938 |
| April 17, 2024 | 5.881 |
| April 16, 2024 | 5.932 |
| April 15, 2024 | 5.963 |
| April 12, 2024 | 5.935 |
| April 11, 2024 | 6.038 |
| April 10, 2024 | 6.182 |
| April 09, 2024 | 6.343 |
| April 08, 2024 | 6.281 |
| April 05, 2024 | 6.308 |
| April 04, 2024 | 6.318 |
| April 03, 2024 | 6.414 |
| Date | Value |
|---|---|
| April 02, 2024 | 6.483 |
| April 01, 2024 | 6.514 |
| March 31, 2024 | |
| March 28, 2024 | 3.735 |
| March 27, 2024 | 3.667 |
| March 26, 2024 | 3.619 |
| March 25, 2024 | 3.598 |
| March 22, 2024 | 3.576 |
| March 21, 2024 | 3.553 |
| March 20, 2024 | 3.573 |
| March 19, 2024 | 3.567 |
| March 18, 2024 | 3.553 |
| March 15, 2024 | 3.604 |
| March 14, 2024 | 3.615 |
| March 13, 2024 | 3.618 |
| March 12, 2024 | 3.738 |
| March 11, 2024 | 3.735 |
| March 08, 2024 | 3.696 |
| March 07, 2024 | 3.661 |
| March 06, 2024 | 3.668 |
| March 05, 2024 | 3.561 |
| March 04, 2024 | 3.499 |
| March 01, 2024 | 3.497 |
| February 29, 2024 | 3.487 |
| February 28, 2024 | 3.499 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.034
Minimum
Mar 23 2020
8.520
Maximum
Dec 27 2019
4.083
Average
4.000
Median
Price to Book Value Benchmarks
| Amgen Inc | 32.83 |
| Gilead Sciences Inc | 4.637 |
| Johnson & Johnson | 5.120 |
| Karuna Therapeutics Inc (DELISTED) | 10.05 |
| 2seventy bio Inc | 0.8994 |
Price to Book Value Related Metrics
| PS Ratio | 1.971 |
| Price to Free Cash Flow | 7.176 |
| Price | 43.67 |
| Earnings Yield | -7.10% |
| Market Cap | 88.52B |
| Operating PE Ratio | 12.34 |
| Normalized PE Ratio | 56.54 |